Impact of cytochrome P-450 inhibition by cimetidine and induction by carbamazepine on the kinetics of hypericin and pseudohypericin in healthy volunteers

European Journal of Clinical Pharmacology
Andreas JohneIvar Roots

Abstract

This study evaluated the influence of cimetidine and carbamazepine on the pharmacokinetics of the St. John's wort (SJW) ingredients hypericin and pseudohypericin. In a placebo-controlled, double blind study, 33 healthy volunteers were randomized into three treatment groups that received SJW extract (LI160) with different comedications (placebo, cimetidine, and carbamazepine) for 7 days after a run-in period of 11 days with SJW alone. Hypericin and pseudohypericin pharmacokinetics were measured on days 10 and 17. Between-group comparisons showed no statistically significant differences in AUC(0-24), C(max), and t(max) values for hypericin and pseudohypericin. Within-group comparisons, however, revealed a statistically significant increase in hypericin AUC(0-24) from a median of 119 (range 82-163 microg h/l) to 149 microg h/l (61-202 microg h/l) with cimetidine comedication and a decrease in pseudohypericin AUC(0-24) from a median of 51.0 (16.4-102.9 microg h/l) to 36.4 microg h/l (14.0-102.0 microg h/l) with carbamazepine comedication compared to the baseline pharmacokinetics in each group. Hypericin and pseudohypericin pharmacokinetics were only marginally influenced by comedication with the enzyme inhibitors and inducers cimet...Continue Reading

References

May 1, 1987·Clinical Pharmacokinetics·A Somogyi, M Muirhead
Nov 1, 1995·Pharmacopsychiatry·F AlbaniA Baruzzi
Sep 1, 1996·Antimicrobial Agents and Chemotherapy·R KerbI Roots
Oct 31, 1997·Journal of Pharmaceutical Sciences·S SattlerC M Lehr
Oct 21, 1999·International Journal of Pharmaceutics·A R KamuhabwaP A de Witte
Feb 22, 2000·Lancet·S C PiscitelliJ Falloon
Feb 17, 2001·Clinical Pharmacology and Therapeutics·D DürrK Fattinger
Feb 24, 2001·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·M AgrosiD Savio
Apr 25, 2001·British Journal of Clinical Pharmacology·A OwenB K Park
Dec 12, 2001·British Journal of Pharmacology·M D PerloffD J Greenblatt
Feb 19, 2002·The International Journal of Biochemistry & Cell Biology·Patrizia AgostinisPeter A M de Witte
Aug 22, 2002·Journal of the National Cancer Institute·Ron H J MathijssenAlex Sparreboom
Sep 12, 2002·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Volker Schulz
Nov 14, 2002·European Urology·Marie-Ange D'HallewinFrançois Guillemin
Mar 15, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ingrid MaiIvar Roots
Apr 8, 2003·European Journal of Pharmacology·Solveigh KrusekopfUllrich Kleeberg
May 7, 2003·Clinical Pharmacology and Therapeutics·Yorki TayrouzGerd Mikus

❮ Previous
Next ❯

Citations

Jan 20, 2012·Clinical Pharmacokinetics·Shaojun Shi, Ulrich Klotz
Mar 13, 2014·The Journal of Antimicrobial Chemotherapy·Akil JacksonMarta Boffito
Oct 18, 2005·The Medical Clinics of North America·Christopher P HolstegeR Brent Furbee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.